Sandoz Inc - Strategic SWOT Analysis Review
Sandoz Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
Sandoz Inc (Sandoz), a division of Novartis AG, is a generic pharmaceutical company which develops, manufactures and distributes and sells a range of prescription medicines and protein and biosimilars worldwide. The company also provides intermediary products including active pharmaceutical ingredients (APIs), and biotechnology manufacturing services to other companies. It provides active ingredients and finished dosage forms of pharmaceuticals in the areas of dermatology, cancer, cardiovascular, respiratory, metabolism, central nervous system, pain, ophthalmic, gastrointestinal and hormonal therapies. Sandoz distributes products to wholesalers, pharmacies, hospitals and other healthcare outlets. Sandoz is headquartered in Princeton, New Jersey, the US.
Sandoz Inc Key Recent Developments
May 19,2021: Sandoz plans $183m boost to antibiotics production in Europe
May 14,2021: Courts approve settlement of Canadian ACTOS / Pioglitazone litigation
Feb 12,2021: Sandoz signs $500m deal to acquire GSK’s cephalosporin antibiotics business
Dec 08,2020: Sandoz generic injectable acetaminophen immediately available to US patients, strategically building hospital portfolio offering
Dec 01,2020: OpGen Group company Ares Genetics advances ares-genetics.Cloud platform, presents update at scientific conferences, expects granting of key patent
Reasons to Buy
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Sandoz Inc (Sandoz), a division of Novartis AG, is a generic pharmaceutical company which develops, manufactures and distributes and sells a range of prescription medicines and protein and biosimilars worldwide. The company also provides intermediary products including active pharmaceutical ingredients (APIs), and biotechnology manufacturing services to other companies. It provides active ingredients and finished dosage forms of pharmaceuticals in the areas of dermatology, cancer, cardiovascular, respiratory, metabolism, central nervous system, pain, ophthalmic, gastrointestinal and hormonal therapies. Sandoz distributes products to wholesalers, pharmacies, hospitals and other healthcare outlets. Sandoz is headquartered in Princeton, New Jersey, the US.
Sandoz Inc Key Recent Developments
May 19,2021: Sandoz plans $183m boost to antibiotics production in Europe
May 14,2021: Courts approve settlement of Canadian ACTOS / Pioglitazone litigation
Feb 12,2021: Sandoz signs $500m deal to acquire GSK’s cephalosporin antibiotics business
Dec 08,2020: Sandoz generic injectable acetaminophen immediately available to US patients, strategically building hospital portfolio offering
Dec 01,2020: OpGen Group company Ares Genetics advances ares-genetics.Cloud platform, presents update at scientific conferences, expects granting of key patent
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
SECTION 1 - ABOUT THE COMPANY
Sandoz Inc - Key Facts
Sandoz Inc - Key Employees
Sandoz Inc - Major Products and Services
Sandoz Inc - History
Sandoz Inc - Company Statement
Sandoz Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Sandoz Inc - Business Description
Business Segment: Anti-Infectives
Overview
Performance
Business Segment: Biopharmaceuticals
Overview
Performance
Business Segment: Retail Generics
Overview
Performance
Geographical Segment: Asia/Africa/Australasia
Performance
Geographical Segment: Canada and Latin America
Performance
Geographical Segment: Europe
Performance
Geographical Segment: The US
Performance
Sandoz Inc - SWOT Analysis
SWOT Analysis - Overview
Sandoz Inc - Strengths
Sandoz Inc - Weaknesses
Sandoz Inc - Opportunities
Sandoz Inc - Threats
Sandoz Inc - Key Competitors
SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sandoz Inc, Recent Deals Summary
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
May 19, 2021: Sandoz plans $183m boost to antibiotics production in Europe
May 14, 2021: Courts approve settlement of Canadian ACTOS / Pioglitazone litigation
Dec 08, 2020: Sandoz generic injectable acetaminophen immediately available to US patients, strategically building hospital portfolio offering
Dec 01, 2020: OpGen Group company Ares Genetics advances ares-genetics.Cloud platform, presents update at scientific conferences, expects granting of key patent
Oct 01, 2020: Sandoz launches its first RFID-tagged critical injectable medicines with Kit Check to optimize supply chain and automate restocking in US hospitals
Oct 01, 2020: Kit Check and Sandoz collaborate to launch RFID-tagged generic injectables in October 2020
Aug 18, 2020: DoseID launches to expand RFID interoperability and performance in healthcare
Jul 28, 2020: Sandoz partners with Austria to boost antibiotics production
Jul 07, 2020: Sandoz collaborates with Civica Rx to help reduce critical generic medicine shortages in US hospitals
Jun 10, 2020: Attorney General Tong leads coalition filing 3rd complaint in ongoing antitrust price-fixing investigation into generic drug industry
SECTION 5 – APPENDIX
Methodology
About GlobalData
Contact Us
Disclaimer
Sandoz Inc - Key Facts
Sandoz Inc - Key Employees
Sandoz Inc - Major Products and Services
Sandoz Inc - History
Sandoz Inc - Company Statement
Sandoz Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Sandoz Inc - Business Description
Business Segment: Anti-Infectives
Overview
Performance
Business Segment: Biopharmaceuticals
Overview
Performance
Business Segment: Retail Generics
Overview
Performance
Geographical Segment: Asia/Africa/Australasia
Performance
Geographical Segment: Canada and Latin America
Performance
Geographical Segment: Europe
Performance
Geographical Segment: The US
Performance
Sandoz Inc - SWOT Analysis
SWOT Analysis - Overview
Sandoz Inc - Strengths
Sandoz Inc - Weaknesses
Sandoz Inc - Opportunities
Sandoz Inc - Threats
Sandoz Inc - Key Competitors
SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sandoz Inc, Recent Deals Summary
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
May 19, 2021: Sandoz plans $183m boost to antibiotics production in Europe
May 14, 2021: Courts approve settlement of Canadian ACTOS / Pioglitazone litigation
Dec 08, 2020: Sandoz generic injectable acetaminophen immediately available to US patients, strategically building hospital portfolio offering
Dec 01, 2020: OpGen Group company Ares Genetics advances ares-genetics.Cloud platform, presents update at scientific conferences, expects granting of key patent
Oct 01, 2020: Sandoz launches its first RFID-tagged critical injectable medicines with Kit Check to optimize supply chain and automate restocking in US hospitals
Oct 01, 2020: Kit Check and Sandoz collaborate to launch RFID-tagged generic injectables in October 2020
Aug 18, 2020: DoseID launches to expand RFID interoperability and performance in healthcare
Jul 28, 2020: Sandoz partners with Austria to boost antibiotics production
Jul 07, 2020: Sandoz collaborates with Civica Rx to help reduce critical generic medicine shortages in US hospitals
Jun 10, 2020: Attorney General Tong leads coalition filing 3rd complaint in ongoing antitrust price-fixing investigation into generic drug industry
SECTION 5 – APPENDIX
Methodology
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Sandoz Inc, Key Facts
Sandoz Inc, Key Employees
Sandoz Inc, Major Products and Services
Sandoz Inc, History
Sandoz Inc, Other Locations
Sandoz Inc, Subsidiaries
Sandoz Inc, Key Competitors
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sandoz Inc, Recent Deals Summary
Sandoz Inc, Key Facts
Sandoz Inc, Key Employees
Sandoz Inc, Major Products and Services
Sandoz Inc, History
Sandoz Inc, Other Locations
Sandoz Inc, Subsidiaries
Sandoz Inc, Key Competitors
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Sandoz Inc, Recent Deals Summary
LIST OF FIGURES
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sandoz Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
Sandoz Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Sandoz Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021